Duquesne Family Office LLC / RARE
Duquesne Family Office LLC’s Ultragenyx Pharmaceutical In Position
Does Duquesne Family Office LLC own Ultragenyx Pharmaceutical In (RARE)? Not currently — the last reported position was 85.4K shares worth $3M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q1 2025
Shares
85.4K
% of Portfolio
+0.10%
Quarters Held
3
position exited
Position History RARE
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of RARE.